Campbell & Co Investment Adviser’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Buy
+4,600
New +$224K 0.01% 941
2026
Q1
– Sell
-41,982
Closed -$1.84M – 1170
2025
Q4
$1.84M Buy
+41,982
New +$1.74M 0.09% 354
2025
Q3
– Sell
-81,729
Closed -$3.6M – 1186
2025
Q2
$3.6M Buy
+81,729
New +$3.27M 0.23% 91
2024
Q4
– Sell
-17,985
Closed -$467K – 1140
2024
Q3
$467K Buy
+17,985
New +$447K 0.03% 743
2024
Q2
– Sell
-19,108
Closed -$453K – 1130
2024
Q1
$453K Buy
+19,108
New +$425K 0.04% 743
2022
Q4
– Sell
-23,752
Closed -$372K – 834
2022
Q3
$372K Buy
+23,752
New +$459K 0.08% 409
2019
Q1
– Sell
-18,481
Closed -$403K – 542
2018
Q4
$403K Buy
+18,481
New +$329K 0.4% 74

Other funds holding EXEL

Campbell & Co Investment Adviser's EXEL Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Exelixis (EXEL) in Q2 2026: 4,600 shares worth $250K. The stake represents 0.01% of the portfolio and ranks #941 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in EXEL as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in EXEL in Q4 2018 and has held it in 7 quarters since. The position peaked at $3.6M in Q2 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Campbell & Co Investment Adviser held 4,600 shares of Exelixis worth $250K as of Q2 2026.
  • Exelixis was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Exelixis made up 0.01% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #941 holding.
  • Campbell & Co Investment Adviser first reported a position in Exelixis in Q4 2018 and has held it in 7 quarters since.
  • Campbell & Co Investment Adviser's Exelixis position peaked at $3.6M in Q2 2025.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.